Featured Research

from universities, journals, and other organizations

Breast Cancer Risk Elevated In Male BRCA Mutation Carriers

Date:
November 29, 2007
Source:
Journal of the National Cancer Institute
Summary:
Men with mutations in the BRCA1 or BRCA2 genes are at greater risk of breast cancer than the general population. Male breast cancer accounts for less than 1 percent of all breast cancers in the U.S., and it is most common in men with a family history of the disease. Previous studies have shown that men who carry mutations in the BRCA2 gene have a greater risk of developing breast cancer than men in the general population. The association between BRCA1 mutations and breast cancer in men was less clear.

Men with mutations in the BRCA1 or BRCA2 genes are at greater risk of breast cancer than the general population.

Male breast cancer accounts for less than 1 percent of all breast cancers in the U.S., and it is most common in men with a family history of the disease. Previous studies have shown that men who carry mutations in the BRCA2 gene have a greater risk of developing breast cancer than men in the general population.

The association between BRCA1 mutations and breast cancer in men was less clear.

Sining Chen, Ph.D., of Johns Hopkins University and colleagues analyzed data from the National Cancer Institute's Cancer Genetics Network on 1,939 families including 97 men with breast cancer.

The risk of developing breast cancer was higher in male BRCA1 and BRCA2 mutation carriers, compared with noncarriers, but BRCA2 mutation carriers had the highest risk. The relative risk was greatest for men in their 30s and 40s and decreased with age. The estimated breast cancer risk of a 70 year old male BRCA2 mutation carrier was 6.8 percent, compared with 1.2 percent for BRCA1 mutation carriers.

"Such risk estimates are important for determining appropriate risk management strategies for the male members of families with germline mutations in BRCA1 or BRCA2," the authors write.


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Journal of the National Cancer Institute. "Breast Cancer Risk Elevated In Male BRCA Mutation Carriers." ScienceDaily. ScienceDaily, 29 November 2007. <www.sciencedaily.com/releases/2007/11/071127171305.htm>.
Journal of the National Cancer Institute. (2007, November 29). Breast Cancer Risk Elevated In Male BRCA Mutation Carriers. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2007/11/071127171305.htm
Journal of the National Cancer Institute. "Breast Cancer Risk Elevated In Male BRCA Mutation Carriers." ScienceDaily. www.sciencedaily.com/releases/2007/11/071127171305.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins